Dr Agarwals Eye Hospital Ltd
NSE: DRAGARWQ BSE: 526783Healthcare
Dr Agarwal's Eye Hospital Ltd is a leading chain of eye hospitals with predominant presence in Tamil Nadu.[1]
₹5,093
52W: ₹4090 — ₹6392
PE 35.2 · Book ₹651 · +682% vs bookMarket Cap₹2,461 Cr
Stock P/E35.2Price to Earnings
ROCE17.5%Return on Capital
ROE29.5%Return on Equity
Div. Yield0.13%Face Value ₹10
Strengths
- +Company has delivered good profit growth of 32.0% CAGR over last 5 years
- +Company has a good return on equity (ROE) track record: 3 Years ROE 33.2%
Weaknesses
- −Stock is trading at 7.70 times its book value
- −Company might be capitalizing the interest cost
- −Promoters have pledged 29.3% of their holding.
Shareholding Pattern
Promoters72.67%
FIIs2.2%
DIIs2.12%
Public22.99%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 71.9% | 71.9% | 71.9% | 71.9% | 71.9% | 72.67%▲0.8 | 72.67% | 72.67% |
| FIIs | 0.65% | 0.83%▲0.2 | 0.84%▲0.0 | 1.33%▲0.5 | 1.49%▲0.2 | 1.74%▲0.3 | 1.82%▲0.1 | 2.2%▲0.4 |
| DIIs | 0% | 0.96%▲1.0 | 1.04%▲0.1 | 1.95%▲0.9 | 2.31%▲0.4 | 2.36%▲0.0 | 2.36% | 2.12%▼0.2 |
| Public | 27.46% | 26.32%▼1.1 | 26.22%▼0.1 | 24.82%▼1.4 | 24.29%▼0.5 | 23.22%▼1.1 | 23.15%▼0.1 | 22.99%▼0.2 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 84 | 76 | 81 | 100 | 102 | 95 | 100 | 117 | 118 | 116 |
| Expenses | 61 | 55 | 56 | 69 | 72 | 69 | 68 | 80 | 78 | 82 |
| Operating Profit | 23 | 21 | 24 | 31 | 30 | 26 | 32 | 37 | 40 | 34 |
| OPM % | 28% | 27% | 30% | 31% | 29% | 27% | 32% | 32% | 34% | 30% |
| Net Profit | 13 | 9 | 13 | 14 | 14 | 10 | 16 | 17 | 19 | 17 |
| EPS ₹ | 26.79 | 20.09 | 27.21 | 30.02 | 30.11 | 22.13 | 34.02 | 36.72 | 39.98 | 35.76 |
AI Insights
Revenue Trend
TTM revenue at ₹451Cr, up 13.6% YoY. OPM at 32%.
Debt Position
Borrowings at ₹335Cr. Debt-to-equity ratio: 1.08x. High leverage — monitor closely.
Capex Cycle
CWIP at ₹157Cr (38% of fixed assets). Significant capex underway — growth runway building.
Institutional Flow
DIIs: 2.12% (+2.12pp change). FIIs: 2.2% (+2.20pp change). Promoters hold 72.67%.
Margin & Efficiency
ROCE improving from 17% (Mar 2014) to 18% (Mar 2025). Working capital days: -51.
Valuation
PE 35.2x with 17.5% ROCE. Price is 682% above book value of ₹651. Dividend yield: 0.13%.
Recent Announcements
- Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results Of The Company For The Quarter And Year Ended March 31, 2026 14 May - Board meets May 20, 2026 to approve FY26 audited results and consider final dividend.
- Receipt Of Order Passed By The Hon'Ble NCLT, In Relation To The Scheme Of Amalgamation Between Dr. Agarwal'S Eye Hospital Limited And Dr. Agarwal'S Health Care Limited 11 May - NCLT allowed meetings for AEHL-AHCL amalgamation scheme on July 2, 2026.
- Trading And Admission To Dealings Of The Company'S Equity Shares On The National Stock Exchange Of India Limited 21 Apr - Dr Agarwal’s Eye Hospital shares admitted to trade on NSE from April 20, 2026, symbol DRAGARWQ.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Apr - Disclosure under Regulation 74(5) of SEBI (DP) Regulations is submitted.
- Closure of Trading Window 24 Mar
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse